7 unknown, 2 recruiting, 2 withdrawn. 11 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 7, Recruiting 2, Withdrawn 2 |
| Phase 3 | 2 | Withdrawn 2 |
Follow pirarubicin: new trials by email Literature Review of pirarubicin trials Research Report on pirarubicin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma Trilaciclib, Pirarubicin, Lobaplatin - Osteosarcoma | Phase 2 | Recruiting | Peking University People's Hospital | 50 | 2024-11-13 | 2024-12-03 |
| Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy Epirubicin or Pirarubicin, Cyclophosphamide - Triple Negative Breast Cancer | Phase 2 | Recruiting | Chinese Academy of Medical Sciences | 286 | 2020-02-01 | 2020-06-18 |
| Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma Apatinib Mesylate, Pirarubicin, Ifosfamide, Apatinib Mesylate, Pirarubicin, Ifosfamide - Soft Tissue Sarcoma | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 120 | 2019-06-01 | 2019-10-15 |
| Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma pegylated liposomal doxorubicin, pirarubicin - Progression-free Survival, Overall Survival | Phase 2 / Phase 3 | Withdrawn | Peking University People's Hospital | 2017-11-06 | 2020-05-19 | |
| Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma pirarubicin(THP) - Intravesical Instillation | Phase 2 | Unknown | RenJi Hospital | 220 | 2017-01-01 | 2019-10-09 |
| Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients Pirarubicin - Bladder Recurrence, Upper Tract Urothelial Carcinoma | Phase 2 | Unknown | Peking University First Hospital | 200 | 2016-11-01 | 2016-11-17 |
| Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy Pegylated Liposomal Doxorubicin, Cyclophosphamide, Taxotere - Antineoplastic Combined Chemotherapy Protocols | Phase 2 | Unknown | Jilin University | 160 | 2016-11-01 | 2017-12-29 |
| Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients Pirarubicin - Upper Tract Urothelial Carcinoma, Bladder Recurrence | Phase 2 | Unknown | Peking University First Hospital | 200 | 2016-08-01 | 2017-09-21 |
| Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma Pirarubicin, Oxaliplatin, Lipiodol - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Withdrawn | Guangxi Medical University | 2015-10-01 | 2019-06-04 | |
| Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas pharmorubicin or pirarubicin - Upper Tract Urothelial Carcinoma, Bladder Recurrence | Phase 2 | Unknown | Xuesong Li | 200 | 2015-09-01 | 2015-09-11 |
| Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) Methotrexate, Prednisolone, Dexamethasone - Lymphoblastic Leukemia, Acute | Phase 2 | Unknown | Japan Adult Leukemia Study Group | 120 | 2002-09-01 | 2008-11-14 |
Sarcoma (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Osteosarcoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Triple Negative Breast Neoplasms (1) · Urinary Bladder Neoplasms (1)
Peking University First Hospital (2) · Peking University People's Hospital (2) · Chinese Academy of Medical Sciences (1) · Guangxi Medical University (1) · Japan Adult Leukemia Study Group (1) · Jilin University (1) · RenJi Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Xuesong Li (1)
China (8) · Japan (1)
Aiping Shi, Doctor (1) · Fumihiko Hayakawa, MD (1) · Lequn Li, PhD (1) · Tomoki Naoe, MD (1) · Wei Guo, M.D.and Ph.D. (1)